North America & Europe Companion Animal Diagnostics Imaging Market Size, Share, Growth, Trends | Report 2023-2032
The North America & Europe companion animal diagnostics imaging market was valued at USD 1.87 billion in 2022 and it is predicted to surpass around USD 3.99 billion by 2032 with a CAGR of 7.88% from 2023 to 2032.
Key Pointers
The industry is primarily driven by factors, such as increasing adoption of pet insurance, pet humanization, initiatives by leading companies, and technological advancements. In February 2021, for instance, Fujifilm launched VXR Veterinary X-Ray Room for veterinarians comprising high sensitivity, low-dose DR detectors, and advanced image processing technologies. This expanded the company’s portfolio and supported its growth objectives.
Growing pet humanization combined with an increase in the pet population is expected to fuel the growth of the industry in the coming years. In November 2021, the American Veterinary Medical Association reported that the pet cat and dog population increased significantly in the U.S., from 135.2 million to 143.7 million between 2016 to 2020. Veterinary care expectations are getting closer to human medical care expectations, as more pet owners are forming a deep attachment with their companion animals. Owners are willing to spend more money and time on their pets to provide them with better healthcare.
Various initiatives by leading companies are another important factor contributing to the industry's growth. Esaote Group reported 19% growth in the order book in 2021. Heska Corporation reported a cumulative total installed base of more than 6,000 imaging devices comprising digital radiography, computer radiography, and ultrasound solutions during 2021.IDEXX Laboratories, Inc., on the other hand, reported teleradiology to be one of its fastest-growing businesses during 2022. The company also reported an increase in active installed bases, higher realized prices, and higher service revenue during 2022.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on North America & Europe Companion Animal Diagnostics Imaging Market
5.1. COVID-19 Landscape: North America & Europe Companion Animal Diagnostics Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. North America & Europe Companion Animal Diagnostics Imaging Market, By Animal Type
8.1. North America & Europe Companion Animal Diagnostics Imaging Market, by Animal Type, 2023-2032
8.1.1. Dogs
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Cats
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Horses
8.1.3.1. Market Revenue and Forecast (2019-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 9. North America & Europe Companion Animal Diagnostics Imaging Market, By Solutions
9.1. North America & Europe Companion Animal Diagnostics Imaging Market, by Solutions, 2023-2032
9.1.1. Equipment
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Consumables
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Services
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. PACS
9.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 10. North America & Europe Companion Animal Diagnostics Imaging Market, By Application
10.1. North America & Europe Companion Animal Diagnostics Imaging Market, by Application, 2023-2032
10.1.1. Orthopedics & Traumatology
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Cardiology
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Neurology
10.1.4.1. Market Revenue and Forecast (2019-2032)
10.1.5. Dental
10.1.5.1. Market Revenue and Forecast (2019-2032)
10.1.6. Internal Medicine
10.1.6.1. Market Revenue and Forecast (2019-2032)
10.1.7. Emergency Critical Care
10.1.7.1. Market Revenue and Forecast (2019-2032)
10.1.8. Theriogenology
10.1.8.1. Market Revenue and Forecast (2019-2032)
Chapter 11. North America & Europe Companion Animal Diagnostics Imaging Market, By End-use
11.1. North America & Europe Companion Animal Diagnostics Imaging Market, by End-use, 2023-2032
11.1.1. Clinics/Hospitals
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Laboratories
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. University/Research Institutes & Others
11.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 12. North America & Europe Companion Animal Diagnostics Imaging Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.1.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.1.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.4. Market Revenue and Forecast, by End-use (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.1.6.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.2.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.5.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.6.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.7.4. Market Revenue and Forecast, by End-use (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Solutions (2019-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2019-2032)
12.2.8.4. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 13. Company Profiles
13.1. IDEXX Laboratories, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. SOUND
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Heska Corp.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ESAOTE SPA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Canon Medical Systems Corp.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Siemens Healthcare Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. FUJIFILM Holdings America Corp.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Hallmarq Veterinary Imaging
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Carestream Health
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Agfa-Gevaert Group
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers